Search for: "William A Grant" Results 681 - 700 of 9,032
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
This patent law entered into force in 1985 and prohibited patent granting for pharmaceutical substances and products. [read post]
17 Nov 2022, 9:05 pm by Zoe Stern
In turn, Jackson and Mark proposed that the executive rulemaking process clarify the scope of the Secretary’s power to grant loan forgiveness. [read post]
17 Nov 2022, 7:16 am by Richard Marsolais
Williams granted Running Buddy’s motion in October 2021, ruling that even though plaintiff  sold over 800,000 Pocket Pluses throughout the United States “multiple competitive products similar to the trade dress also participated in the market. [read post]
16 Nov 2022, 1:30 am by Kluwer Patent blogger
The system will cover a market the size of the US market, with rules tailored to patent proceedings, and with courts that are set up to deliver timely decisions and that are staffed with experienced judges used to granting injunctions in case of infringement. [read post]
15 Nov 2022, 4:47 am by Emma Snell
RESPONSE CIA director William Burns met with this Russian counterpart in Turkey yesterday. [read post]
15 Nov 2022, 1:35 am by Kluwer Patent blogger
‘As of that date, patent applicants may file early requests for unitary effect and requests for a delay in issuing the decision to grant a European patent. [read post]
14 Nov 2022, 12:53 pm by Bonnie Shucha
  The program was part of the excellent Integrating Doctrine and Diversity series from Roger Williams School of Law. [read post]
14 Nov 2022, 2:12 am by INFORRM
The appeal related to an anti-SLAPP motion that had been granted to the respondent pursuant to s.137 of the Courts and Justice Act RSO 1990. [read post]
13 Nov 2022, 9:00 pm by Austin Sarat
Austin Sarat is the William Nelson Cromwell Professor of Jurisprudence and Political Science at Amherst College. [read post]
8 Nov 2022, 8:56 pm by Kurt R. Karst
William Maisel, Chief Medical Officer and Director at CDRH’s Office of Product Evaluation and Quality, shared FDA’s experience with EUAs over the last two and a half years as well as more detail on transition planning for those devices marketed under an EUA or enforcement policy (EP). [read post]